Dr. Vijaya K. Chapala, MD

Dr. Chapala practices at Porter Hospital - Unit in Portage, Indiana.

Dr. Chapala's NPI, 1174573281, was assigned on May 11, 2006. Dr. Chapala holds Indiana license 01076855A.

Dr. Chapala's primary practice is Porter Hospital - Unit, at 3630 Willowcreek Rd, Portage, IN 46368.

Dr. Chapala's primary practice is Porter Hospital - Unit in Portage, Indiana. Dr. Chapala is also affiliated with Northwestern Medicine Central DuPage Hospital. The medical group on file is RUSH Physical Therapy. Dmand AI also links Dr. Chapala to 2 more hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account. Dr. Chapala's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chapala practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Chapala's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Chapala is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Chapala's licenses on file in 3 states: Indiana, Arizona and North Carolina.

CMS data shows 1,127 Medicare services from Dr. Chapala across 10 procedure codes in 2024, for 286 Medicare patients. Medicare paid $96,139 for them. Every service was in an office.

CMS counts 286 Medicare patients who saw Dr. Chapala in 2024. The largest group is 65 to 74, with 150 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chapala's median patient age at 70, with 68% women.

In 2024, Dr. Chapala wrote 4,785 Medicare Part D claims for 419 patients. 88% of them were for generic drugs. CMS names the drug for 4,050 of them, across 96 drugs with 11 or more claims each, at $268,523 in total drug cost. In 2023, CMS named 2,944 claims across 81 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Chapala for performance year 2024, reported through an alternative payment model (APM). Dr. Chapala accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 232 general payments to Dr. Chapala from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Novo Nordisk Inc paid the most, $530.